Related references
Note: Only part of the references are listed.Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors
Steven T. Sizemore et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Principles and methods of integrative genomic analyses in cancer
Vessela N. Kristensen et al.
NATURE REVIEWS CANCER (2014)
Dysregulation of the epigenome in triple-negative breast cancers: Basal-like and claudin-low breast cancers express aberrant DNA hypermethylation
J. Devon Roll et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
A Methyl-Deviator Epigenotype of Estrogen Receptor-Positive Breast Carcinoma Is Associated with Malignant Biology
J. Keith Killian et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Genome-Wide DNA Methylation Profiling of CpG Islands in Breast Cancer Identifies Novel Genes Associated with Tumorigenicity
Victoria K. Hill et al.
CANCER RESEARCH (2011)
Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
Mary Jo Fackler et al.
CANCER RESEARCH (2011)
CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer
Olafur Andri Stefansson et al.
EPIGENETICS (2011)
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
Sitharthan Kamalakaran et al.
MOLECULAR ONCOLOGY (2011)
Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer
Jo Anders Ronneberg et al.
MOLECULAR ONCOLOGY (2011)
Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
Fang Fang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status
James M. Flanagan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance
Natalie E. Simpson et al.
CANCER RESEARCH (2010)
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
Torsten O. Nielsen et al.
CLINICAL CANCER RESEARCH (2010)
Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer
Lian Li et al.
HUMAN MOLECULAR GENETICS (2010)
Breast Cancer Epigenetics: From DNA Methylation to microRNAs
Juergen Veeck et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Enhanced mRNA cap methylation increases Cyclin D1 expression and promotes cell transformation
V. H. Cowling
ONCOGENE (2010)
Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination
Ilse Van der Auwera et al.
PLOS ONE (2010)
Breast Cancer DNA Methylation Profiles Are Associated with Tumor Size and Alcohol and Folate Intake
Brock C. Christensen et al.
PLOS GENETICS (2010)
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
Karolina Holm et al.
BREAST CANCER RESEARCH (2010)
DNA methylation epigenotypes in breast cancer molecular subtypes
Naiara G. Bediaga et al.
BREAST CANCER RESEARCH (2010)
MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells
Norishige Yamada et al.
CANCER RESEARCH (2008)
Methylation of CpG islands of p16INK4a and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast
Tieju Liu et al.
HUMAN PATHOLOGY (2008)
Variation in breast cancer hormone receptor and HER2 levels by etiologic factors:: A population-based analysis
Mark E. Sherman et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Differences in risk factors for breast cancer molecular subtypes in a population-based study
Xiaohong R. Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue
Pearlly S. Yan et al.
CLINICAL CANCER RESEARCH (2006)
Established breast cancer risk factors by clinically important tumour characteristics
M. Garcia-Closas et al.
BRITISH JOURNAL OF CANCER (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
L Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
DNA methylation and breast carcinogenesis
M Widschwendter et al.
ONCOGENE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Share Paper
